| Athome Healthcare Team, Llc | |
| 100 Tower Road, Suite 15, American Canyon, California 94503 | |
| (707) 255-4401 | |
| Name | Athome Healthcare Team, Llc |
|---|---|
| Location | 100 Tower Road, Suite 15, American Canyon, California |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
| Medicare ID | 59644 |
| Ownership Type | Proprietary |
| Service Area Zip Codes | 94501, 94503, 94508, 94509, 94510, 94511, 94513, 94518, 94519, 94520, 94521, 94523, 94525, 94526, 94530, 94531, 94533, 94534, 94535, 94544, 94547, 94548, 94549, 94550, 94553, 94558, 94559, 94561, 94564, 94565, 94571, 94572, 94579, 94583, 94585, 94589, 94590, 94591, 94595, 94596, 94597, 94598, 94599, 94606, 94609, 94610, 94611, 94612, 94619, 94621, 94801, 94803, 94804, 94805, 94806, 94901, 94904, 94928, 94945, 94949, 94952, 94960, 94965, 95401, 95402, 95403, 95404, 95405, 95407, 95409, 95446, 95448, 95472, 95476, 95610, 95620, 95624, 95625, 95687, 95688, 95696, 95825, 95829 |
| NPI Number | 1285043141 |
| Organization Name | ATHOME HEALTHCARE TEAM, LLC |
| Address | 100 Tower Rd, Suite 15 Mailbox # 8, American Canyon, CA 94503 |
| Phone Number | 707-255-4401 |
News Archive
ArQule, Inc. and Daiichi Sankyo, Co., Ltd. today announced that recruitment of patients has been completed in the randomized, double-blind, controlled Phase 3 MARQUEE pivotal trial of their investigational selective c-MET inhibitor, tivantinib, in combination with erlotinib in previously treated patients with locally advanced or metastatic, non-squamous, non-small cell lung cancer.
Substantial evidence suggests that lifespan is increased if an organism restricts its daily calorie intake, a spartan regime that some say works by just making life seem longer. A team of scientists from the Salk Institute of Biological Studies has discovered a molecular switch flipped by hunger that could not only make longevity more appetizing but identify drug targets for patients with aging-related diseases such as type II diabetes or cancer.
GlaxoSmithKline announced today that the U.S. Centers for Disease Control (CDC) Advisory Committee on Immunization Practices (ACIP) voted for a Category B recommendation for meningococcal group B vaccination, including BEXSERO (Meningococcal Group B Vaccine), in individuals aged 16 to 23 (with a preferred age of 16-18).
PharMerica Corporation, a national provider of pharmacy services, today reported its financial results for the second quarter and six months ended June 30, 2013.
› Verified 5 days ago
| Quality Rating: |
News Archive
ArQule, Inc. and Daiichi Sankyo, Co., Ltd. today announced that recruitment of patients has been completed in the randomized, double-blind, controlled Phase 3 MARQUEE pivotal trial of their investigational selective c-MET inhibitor, tivantinib, in combination with erlotinib in previously treated patients with locally advanced or metastatic, non-squamous, non-small cell lung cancer.
Substantial evidence suggests that lifespan is increased if an organism restricts its daily calorie intake, a spartan regime that some say works by just making life seem longer. A team of scientists from the Salk Institute of Biological Studies has discovered a molecular switch flipped by hunger that could not only make longevity more appetizing but identify drug targets for patients with aging-related diseases such as type II diabetes or cancer.
GlaxoSmithKline announced today that the U.S. Centers for Disease Control (CDC) Advisory Committee on Immunization Practices (ACIP) voted for a Category B recommendation for meningococcal group B vaccination, including BEXSERO (Meningococcal Group B Vaccine), in individuals aged 16 to 23 (with a preferred age of 16-18).
PharMerica Corporation, a national provider of pharmacy services, today reported its financial results for the second quarter and six months ended June 30, 2013.
› Verified 5 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often the home health team began their patients’ care in a timely manner | 97.8 | 95.7 |
| How often the home health team taught patients (or their family caregivers) about their drugs | 98.5 | 98.6 |
| How often the home health team checked patients’ risk of falling | 99.3 | 99.6 |
| How often the home health team checked patients for depression | 96.3 | 97.4 |
| How often the home health team made sure that their patients have received a flu shot for the current flu season. | 64.2 | 78.7 |
| How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 74.6 | 82.2 |
| With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 98.2 | 96.4 |
News Archive
ArQule, Inc. and Daiichi Sankyo, Co., Ltd. today announced that recruitment of patients has been completed in the randomized, double-blind, controlled Phase 3 MARQUEE pivotal trial of their investigational selective c-MET inhibitor, tivantinib, in combination with erlotinib in previously treated patients with locally advanced or metastatic, non-squamous, non-small cell lung cancer.
Substantial evidence suggests that lifespan is increased if an organism restricts its daily calorie intake, a spartan regime that some say works by just making life seem longer. A team of scientists from the Salk Institute of Biological Studies has discovered a molecular switch flipped by hunger that could not only make longevity more appetizing but identify drug targets for patients with aging-related diseases such as type II diabetes or cancer.
GlaxoSmithKline announced today that the U.S. Centers for Disease Control (CDC) Advisory Committee on Immunization Practices (ACIP) voted for a Category B recommendation for meningococcal group B vaccination, including BEXSERO (Meningococcal Group B Vaccine), in individuals aged 16 to 23 (with a preferred age of 16-18).
PharMerica Corporation, a national provider of pharmacy services, today reported its financial results for the second quarter and six months ended June 30, 2013.
› Verified 5 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often patients got better at walking or moving around | 71.9 | 79.6 |
| How often patients got better at getting in and out of bed | 68.4 | 81.1 |
| How often patients got better at bathing | 81 | 82.3 |
| How often patients’ breathing improved | 77.9 | 82.8 |
| How often patients’ wounds improved or healed after an operation | 83.1 | 92.3 |
| How often patients got better at taking their drugs correctly by mouth | 62.4 | 75 |
| How often home health patients had to be admitted to the hospital | 13.8 | 15.4 |
| How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 13.6 | 13 |
| How often physician-recommended actions to address medication issues were completely timely | 96.2 | 94 |
News Archive
ArQule, Inc. and Daiichi Sankyo, Co., Ltd. today announced that recruitment of patients has been completed in the randomized, double-blind, controlled Phase 3 MARQUEE pivotal trial of their investigational selective c-MET inhibitor, tivantinib, in combination with erlotinib in previously treated patients with locally advanced or metastatic, non-squamous, non-small cell lung cancer.
Substantial evidence suggests that lifespan is increased if an organism restricts its daily calorie intake, a spartan regime that some say works by just making life seem longer. A team of scientists from the Salk Institute of Biological Studies has discovered a molecular switch flipped by hunger that could not only make longevity more appetizing but identify drug targets for patients with aging-related diseases such as type II diabetes or cancer.
GlaxoSmithKline announced today that the U.S. Centers for Disease Control (CDC) Advisory Committee on Immunization Practices (ACIP) voted for a Category B recommendation for meningococcal group B vaccination, including BEXSERO (Meningococcal Group B Vaccine), in individuals aged 16 to 23 (with a preferred age of 16-18).
PharMerica Corporation, a national provider of pharmacy services, today reported its financial results for the second quarter and six months ended June 30, 2013.
› Verified 5 days ago
| Question Type: | Rating by Patients |
|---|---|
| Health team gave care in a professional way | |
| Health team communicated well with them | |
| Health team discussed medicines, pain, and home safety | |
| How patients rated overall care from agency |
News Archive
ArQule, Inc. and Daiichi Sankyo, Co., Ltd. today announced that recruitment of patients has been completed in the randomized, double-blind, controlled Phase 3 MARQUEE pivotal trial of their investigational selective c-MET inhibitor, tivantinib, in combination with erlotinib in previously treated patients with locally advanced or metastatic, non-squamous, non-small cell lung cancer.
Substantial evidence suggests that lifespan is increased if an organism restricts its daily calorie intake, a spartan regime that some say works by just making life seem longer. A team of scientists from the Salk Institute of Biological Studies has discovered a molecular switch flipped by hunger that could not only make longevity more appetizing but identify drug targets for patients with aging-related diseases such as type II diabetes or cancer.
GlaxoSmithKline announced today that the U.S. Centers for Disease Control (CDC) Advisory Committee on Immunization Practices (ACIP) voted for a Category B recommendation for meningococcal group B vaccination, including BEXSERO (Meningococcal Group B Vaccine), in individuals aged 16 to 23 (with a preferred age of 16-18).
PharMerica Corporation, a national provider of pharmacy services, today reported its financial results for the second quarter and six months ended June 30, 2013.
› Verified 5 days ago
The patient survey data of Athome Healthcare Team, Llc is compared against the national average with the color code indicators: Better than National Average Worse than National Average| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percent of patients who reported that their home health team gave care in a professional way | 90 | 88 |
| Percent of patients who reported that their home health team communicated well with them | 85 | 85 |
| Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 74 | 83 |
| Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 75 | 84 |
| Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 80 | 78 |
News Archive
ArQule, Inc. and Daiichi Sankyo, Co., Ltd. today announced that recruitment of patients has been completed in the randomized, double-blind, controlled Phase 3 MARQUEE pivotal trial of their investigational selective c-MET inhibitor, tivantinib, in combination with erlotinib in previously treated patients with locally advanced or metastatic, non-squamous, non-small cell lung cancer.
Substantial evidence suggests that lifespan is increased if an organism restricts its daily calorie intake, a spartan regime that some say works by just making life seem longer. A team of scientists from the Salk Institute of Biological Studies has discovered a molecular switch flipped by hunger that could not only make longevity more appetizing but identify drug targets for patients with aging-related diseases such as type II diabetes or cancer.
GlaxoSmithKline announced today that the U.S. Centers for Disease Control (CDC) Advisory Committee on Immunization Practices (ACIP) voted for a Category B recommendation for meningococcal group B vaccination, including BEXSERO (Meningococcal Group B Vaccine), in individuals aged 16 to 23 (with a preferred age of 16-18).
PharMerica Corporation, a national provider of pharmacy services, today reported its financial results for the second quarter and six months ended June 30, 2013.
› Verified 5 days ago
Athome Healthcare Team, Llc Location: 100 Tower Road, Suite 15, American Canyon, California 94503 Ratings: Phone: (707) 255-4401 |